Apparatus and method for intravascular measurements

Information

  • Patent Grant
  • 10702170
  • Patent Number
    10,702,170
  • Date Filed
    Tuesday, July 1, 2014
    10 years ago
  • Date Issued
    Tuesday, July 7, 2020
    4 years ago
Abstract
Intravascular diagnosis apparatus and methods are disclosed. In one aspect of the disclosed technology, a intravascular diagnosis apparatus includes a monitoring guidewire and a display unit. The monitoring guidewire includes a core wire and a sensor disposed in a distal region of the core wire. The display unit includes a processor and a display screen, and is capable of receiving communication from the monitoring guidewire. The display unit is configured to perform computations using the processor based on communications received from the monitoring guidewire and is configured to display information on the display screen based on the computations. The display unit can be configured to be disposed after a predetermined number of uses or after a predetermined duration of use.
Description
FIELD OF THE INVENTION

The disclosed technology relates to intravascular diagnosis. More particularly, the disclosed technology relates to diagnosing the severity of stenosis in the vasculature of a patient.


BACKGROUND

Reduced blood flow due to atherosclerotic occlusion of vessels is a major cause of vascular diseases. Pressure measurements in arterial vessels and particularly in coronary arteries prior to treatment have been used for lesion characterization and treatment selection. More specifically, pressure gradient across a lesion has been clinically used as an indicator for lesion severity. Measurements made during and after treatment allow one to assess therapy efficacy. Existing equipment for monitoring intravascular measurements have multiple, separate parts and bulky monitors. There is, accordingly, continuing interest in improved monitoring equipment.


SUMMARY

The disclosed technology relates to diagnosing the severity of stenoses in the vasculature of a patient.


In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a portable display unit configured to be disposed after a predetermined number of uses or after a predetermined duration of use. The portable display unit can include a processor and a display screen, where the portable display unit is capable of receiving communication from the monitoring guidewire, is configured to perform computations using the processor based on communications received from the monitoring guidewire, and is configured to display information on the display screen based on the computations.


In one embodiment, the portable display unit includes one or more batteries configured to power the portable display unit. In one embodiment, the one or more batteries can be rechargeable by a power source of the portable display unit and/or a power source external to the portable display unit.


In one embodiment, the portable display unit further includes one or more batteries configured to power the portable display unit for a predetermined duration of use, such that the portable display unit can be configured to be disposed after the one or more batteries are depleted. In one embodiment, the one or more batteries are non-rechargeable. In one embodiment, the portable display unit can be configured to be inoperable after a one uses.


In one aspect of the disclosed technology, the monitoring guidewire can be configured to be disposed after a single use.


In one embodiment, the portable display unit and the monitoring guidewire can communicate wirelessly. In one embodiment, the portable display unit includes a connector configured to establish a communicative connection with the monitoring guidewire. In one embodiment, the connector is configured to establish a mechanical connection with the monitoring guidewire to control the guidewire within a vasculature. In one embodiment, a torquer is configured to engage the monitoring guidewire to control the guidewire within a vasculature.


In one embodiment, the monitoring guidewire includes a housing surrounding the sensor, and the housing can be laser etched to provide flexibility for the housing. In one embodiment, the monitoring guidewire includes a flexible coil surrounding the sensor, with the coil having a relaxed portion over the sensor.


In one aspect of the disclosed technology, the sensor is a pressure sensor and communication from the monitoring guidewire includes measurements from the pressure sensor. The processor of the portable display unit is capable of computing fractional flow reserve based on pressure measurements from only the pressure sensor in the distal region of the core wire.


In one embodiment, the fractional flow reserve is a push-forward fraction flow reserve (“FFR”) computed as: FFR=(Psensor−Pra)/(Psaved−Pra), where:


Psaved are moving means over time of recorded pressure measurements proximal to a first stenosis,


Psensor are moving means over time of real time pressure measurements distal to the first stenosis, and


Pra is a constant.


In one embodiment, Psaved are moving means over time of recorded pressure measurements proximal to the first stenosis and proximal to a second stenosis. In one embodiment, Psensor are moving means over time of real time pressure measurements distal to the first stenosis and proximal to a second stenosis. In one embodiment, Psensor moving means over time of real time pressure measurements distal to the first stenosis and distal to the second stenosis.


In one embodiment, the fractional flow reserve is a pull-back fraction flow reserve computed as: FFR=(Psaved−)/(Psensor−Pra), where:


Psaved are moving means over time of recorded pressure measurements distal to a first stenosis,


Psensor are moving means over time of real time pressure measurements proximal to the first stenosis, and


Pra is a constant.


In one embodiment, Psensor are moving means over time of real time pressure measurements proximal to the first stenosis and distal to a second stenosis. In one embodiment, Psaved are moving means over time of recorded pressure measurements distal to the first stenosis and distal to a second stenosis. In one embodiment, Psensor are moving means over time of real time pressure measurements proximal to the first stenosis and proximal to the second stenosis.


In one embodiment, the portable display unit displays on the display screen the fractional flow reserve. In one embodiment, the portable display unit displays a graph of the pressure measurements.


In one embodiment, the portable display unit includes a communications port configured to receive communications that include pressure measurements.


In one embodiment, the fractional flow reserve is a pull-back fraction flow reserve computed as: FFR=(Psensor−Pra)/(Pport−Pra), where:


Pport are moving means over time of real-time pressure measurements received at the communications port,


Psensor are moving means over time of real-time pressure measurements from the pressure sensor disposed in the distal region of the core wire, and


Pra is a constant.


In one embodiment, the portable display unit is configured with capability to compute fractional flow reserve in at least two ways: computing fractional flow reserve based on pressure measurements from only the pressure sensor disposed in the distal region of the core wire, and computing fractional flow reserve based on the pressure measurements from the pressure sensor and based on pressure measurements received at a communications port. In one embodiment, the portable display unit can be configured to automatically use one of the at least two ways of computing fractional flow reserve. In one embodiment, the portable display unit can be configured to automatically select one of the ways of computing fractional flow reserve when a condition is present and can be configured to automatically select another of the at least two ways of computing fractional flow reserve when the condition is absent. In one embodiment, the portable display unit can be configured to permit a user to manually select one of the at least two ways of computing fraction flow reserve.


In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a handheld display unit configured to be disposed after a predetermined number of uses or after a predetermined duration of use. The handheld display unit can include a processor and a display screen, where the handheld display unit is capable of receiving communication from the monitoring guidewire, is configured to perform computations using the processor based on communications received from the monitoring guidewire, and is configured to display information on the display screen based on the computations. In one embodiment, the handheld display unit can be equal to or less than 30 cm×30 cm×30 cm in size.


In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a portable display unit capable of receiving communication from the monitoring guidewire. The portable display unit includes a processor and display screen, and is configured to perform computations using the processor based on communications received from the monitoring guidewire and is configured to display information on the display screen based on the computations. The portable display unit has no capability of being turned off after the display screen is turned on,


These aspects and embodiments of the disclosed technology are exemplary and do not limit the scope of the disclosed technology, which will be apparent from a reading of the following detailed description and the associated drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram of an exemplary intravascular diagnosis apparatus in accordance with the disclosed technology.



FIG. 2 is a block diagram of an embodiment of the disclosed technology;



FIG. 3 is a diagram of an exemplary apparatus in accordance with the disclosed technology;



FIG. 4 is another diagram of an exemplary apparatus in accordance with the disclosed technology;



FIG. 5 is a diagram of an exemplary distal tip of the disclosed monitoring guidewire;



FIG. 6 is a diagram of two embodiments of the distal tip of the disclosed monitoring guidewire;



FIG. 7 is a diagram of one position for the disclosed monitoring guidewire for estimating fractional flow reserve;



FIG. 8 is a diagram of another position for the disclosed monitoring guidewire for estimating fractional flow reserve;



FIG. 9 is a flow diagram of exemplary operation of the disclosed technology for computing simultaneous fractional flow reserve;



FIG. 10 is a flow diagram of exemplary operation of the disclosed technology for computing push-forward fractional flow reserve; and



FIG. 11 is a flow diagram of exemplary operation of the disclosed technology for computing pull-back fractional flow reserve.





DETAILED DESCRIPTION

The disclosed technology relates to diagnosing the severity of stenosis in the vasculature of a patient. The disclosed technology can be used as an adjunct to conventional angiographic procedures to provide important quantitative measurements of a blood vessel lumen.


Referring now to FIG. 1, there is shown a block diagram of an exemplary intravascular diagnosis apparatus in accordance with the disclosed technology. The illustrated apparatus 100 includes a monitoring guidewire 102 and a portable display unit 104. In one embodiment, the portable display unit 104 can be a handheld display unit, such that any and all aspects and embodiments described herein as being applicable to a portable display unit are also applicable to the disclosed handheld display unit. In one embodiment, the handheld display unit can be equal to or less than 30 cm×30 cm×30 cm in size. In operation, the monitoring guidewire 102 is introduced into the vasculature of a patient with the assistance of conventional interventional equipment known to those skilled in the art, such as catheters. The portable display unit 104 can communicate with the monitoring guidewire 102 and can display information based on the communications received from the monitoring guidewire 102.


The illustrated monitoring guidewire 102 can include several components, including a core wire 106 and one or more sensors 108 disposed in a distal region of the core wire 106. As used herein, the terms “distal” and “proximal” refer to physical directions within a blood vessel lumen. Specifically, in relation to the insertion point of a device into a patient, the term “distal” refers to the direction from the insertion point inwards into a blood vessel, and the term “proximal” refers to the direction from the inside of a blood vessel out towards the insertion point. As used herein, the terms “proximal” and “distal” can also refer to different ends of a device, with “proximal” being the end towards an insertion point into a blood vessel lumen and with “distal” being the end away from the insertion point.


With continuing reference to FIG. 1, the one or more sensors 108 disposed in a distal region of the core wire 106 can include one or more hemodynamic pressure sensors and/or one or more temperature sensors. In one embodiment, the pressure sensor(s) can be a piezo-resistive pressure sensor. As illustrated in FIG. 1, the monitoring guidewire 102 can also include a protective structure 110 surrounding the sensor(s) 108, and can include a communication unit 112. The protective structure 110 of the monitoring guidewire 102 will be described in more detail later herein in connection with FIGS. 5-6.


In one embodiment, the communication unit 112 can employ wireless communication technology such as bluetooth, WiFi (802.11), or any other wireless technology. In one embodiment, the communication unit 112 can be a wireline communication unit that can include one or more wires for communicating electromagnetic signals and/or one or more optical fibers for communicating optical signals. The monitoring guidewire 102 can include other components that are not illustrated, such as a power source, A/D converters, application specific integrated circuits (ASIC), a processor, memory, timing circuitry, and/or other power, analog, or digital circuitry. Such components will be known to those skilled in the art.


Referring now to the illustrated portable display unit 104, the portable display unit 104 can include a display screen 114, one or more batteries 116, memory and/or storage 118, a communication unit 120, power management unit 122, and a processor 124. In one embodiment, the processor 124 can be a general purpose processor or can be an application specific integrated circuit. In one embodiment, the display screen 114 can be a liquid crystal display, an organic light emitting diode display, or another type of display technology. In one embodiment, the memory/storage 118 can include one or more of solid state memory/storage, magnetic disc storage, and/or any other type of memory/storage that will be known to those skilled in the art. In one embodiment, the memory/storage 118 can include software instructions that are executed by the processor 124. In one embodiment, the communication unit 120 can employ wireless communication technology such as bluetooth, WiFi (802.11), or any other wireless technology. In one embodiment, the communication unit 120 can be a wireline communication unit that can include one or more wires for communicating electromagnetic signals and/or one or more optical fibers for communicating optical signals. The portable display unit 104 can include other components that are not illustrated, such as user interface, operating system software, display driver circuitry, A/D converters, application specific integrated circuits (ASIC), timing circuitry, and/or other power, analog, or digital circuitry. Such components will be known to those skilled in the art.


Referring now to FIG. 2, there is shown a system block diagram of another embodiment of the disclosed technology. The monitoring guidewire contains a pressure sensor and/or other sensors at the distal end. The electrical signals from the sensor(s) can be sent over a wire connection to the portable display unit. The portable display unit can include a communications port that receives external sensor input such as aortic output pressure (AO IN) from pressure transducers/hemodynamic systems (not shown). The portable display unit can also include an output communication port for outputting data to an external storage device, to another display, to a printer, and/or to a hemodynamic system (not shown).


Referring now to FIG. 3, there is shown an exemplary embodiment of the disclosed intravascular diagnosis apparatus. In one embodiment, the monitoring guidewire 302 can be approximately 180 centimeters in length. In other embodiments, the monitoring guidewire 302 can be another length. The monitoring guidewire 302 can have one or more sensors in the distal region 304 of the monitoring guidewire 302. In the illustrated embodiment, the portable display unit 306 can have a small form factor such that it is a handheld display unit. In one embodiment, a handheld display unit can be equal to or less than 30 cm×30 cm×30 cm in size.



FIG. 4 is a diagram of another exemplary embodiment of the disclosed intravascular diagnosis apparatus. In the illustrated embodiment, the monitoring guidewire 402 can be attached and detached from a connector 406 of the portable display unit 400. In one embodiment, the connector 406 can include a button (not shown) which opens an aperture in the connector 406. To attach or detach the monitoring guidewire 402, a user can press and hold the button of the connector 406 and insert the monitoring guidewire 402 into the aperture until the monitoring guidewire 402 is fully inserted into connector 406. Once inserted, the user can release the button, which will then secure the monitoring guidewire 402 in place and provide a connection between the monitoring guidewire 402 and connector 406. In other embodiments, the connector 406 can engage the monitoring guidewire 402 by a screw engagement, a twist engagement, a snap engagement, or an interference fit. The described types of engagement are exemplary and do not limit the scope of the disclosed technology. Other types of ways for the connector 406 to engage the monitoring guidewire 402 are contemplated to be within the scope of the disclosed technology.


In one embodiment, the connector connection establishes a communicative connection between the monitoring guidewire 402 and the portable display unit 400. The monitoring guidewire 402 and the connector 406 can contain electrical wires that connect the monitoring guidewire 402 to the portable display unit 400 and convey signals from the monitoring guidewire sensor(s) to the portable display unit 400.


In one embodiment, the connector connection establishes a mechanical connection between the monitoring guidewire 402 and the connector 406 to control the guidewire 402 within a vasculature. In the illustrated embodiment, the connector 406 is tethered to the main housing 410 of the portable display unit 400. In one embodiment, the tether can be 6 inches to 12 inches long and can allow a user to manipulate the monitoring guidewire 402 freely without the portable display unit main housing 410 being an impediment. In one embodiment, the tether can be another length. In one embodiment (not shown), the connector can be a connection port integrated in the portable display unit main housing 410.


In one embodiment, the connector 406 establishes a communicative connection with the monitoring guidewire 402. In one embodiment, a torquer (not shown) can be configured to engage the monitoring guidewire 402 to control the guidewire within a vasculature when the monitoring guidewire 402 is not mechanically and/or electrically connected to the connector 406. In one embodiment, the torquer can be configured to engage the monitoring guidewire 402 to control the guidewire within a vasculature when the monitoring guidewire 402 is mechanically and/or electrically connected to the connector 406. In one embodiment, the monitoring guidewire 402 does not need a torquer or the connector 406 for insertion into the vasculature of a patient and for navigation therein, and provides this capability by itself.


With continuing reference to FIG. 4, the portable display unit 400 includes a display screen 404 that can display sensor measurements and/or computed information (e.g., fractional flow reserve ratio), in numerical format and/or in waveform format. The portable display unit 400 can include one or more buttons (not shown) or a touch screen to allow a user to provide input to the portable display unit 400. In one embodiment, the screen 404 of the portable display unit can be folded in the main housing 410 before use to minimize the size of packaging when delivering the portal display unit 400. When a user takes the portable display unit 400 out of the packaging for use, the user can pivot the screen 404 from the folded position to an open position (as illustrated), providing an appropriate viewing angle to the user for the diagnosis procedure. In one embodiment, pivoting of the display screen 404 from the folded position to an open position acts as an ON switch that enables power to be delivered to the portable display unit.


In the illustrated embodiment, the portable display unit 400 also includes a communication port 408. In one embodiment, the communication port 408 allows a user to connect the portable display unit 400 to an external system (not shown). The external system can communicate a sensor signal to the portable display unit 400 through the communication port 408. In one embodiment, the sensor signal received at the communication port can be can be a pressure measurement and can be used in calculating fractional flow reserve.


Referring again to FIG. 1, the monitoring guidewire 102 can include a protective structure 110 surrounding the sensor(s) 108. With reference to FIG. 5, there is shown a diagram of an exemplary protective structure 502 surrounding the sensor(s) 510 at the distal region of the monitoring guidewire. In the illustrated embodiment, the protective structure 502 is a housing that has been laser etched with a particular pattern cut to provide flexibility and/or torque translation at the distal tip or portion of the monitoring guidewire where the sensor 510 resides. The sensor(s) 510 can be situated in the laser etched housing at a window 504 in the housing so as to allow blood to contact the sensor(s) 510 in order to take sensor measurements. In the illustrated embodiment, the core wire 508 can be grinded to provide an appropriate profile for balancing flexibility and torque translation. In one embodiment, the monitoring guidewire need not include a core wire 508. Rather, the protective structure 502 can extend along the entire monitoring guidewire or a substantial portion thereof, and can be laser etched along some or all portions to provide desired flexibility and/or torque translation.


Referring to FIG. 6, there is shown a diagram of two exemplary protective structures surrounding the sensor(s) at the distal region of a monitoring guidewire. One of the embodiments is a laser etched housing as described in connection with FIG. 5. The other embodiment provides a coil over the sensor(s) as the protective structure. The coil is relaxed to create a window where the sensor(s) are located to allow blood to contact the sensor(s). The illustrated embodiments are exemplary and do not limit the scope of protective structures contemplated in the disclosed technology. Other protective structures are contemplated to be within the scope of the disclosed technology.


Various aspects and embodiments of the disclosed technology have been described above. The illustrations and descriptions are merely exemplary and do not limit the scope of the disclosed technology. Even though not illustrated, various embodiments can be combined and are contemplated to fall within the scope of the disclosed technology. Furthermore, although certain features are illustrated as being in a particular location or device, the location and device are merely exemplary, and it is contemplated that various features can be located differently than as illustrated and still be within the scope of the disclosed technology.


The following description will now reference FIG. 1, and in particular, the battery 116 and the power management unit 122 of the portable display unit 104. In one aspect of the disclosed technology, the portable display unit 104 can be configured to operate for a predetermined duration or for a predetermined number of uses, and then be disposed. The battery 116 and/or power management unit 122 can implement these features so that the portable display unit 104 can be inoperable after being used for a particular duration or for a particular number of diagnosis procedures. Even so, the portable display unit 104 can be disposed while it is still operable, prior to it being inoperable.


In one embodiment, the predetermined duration can correspond to the approximate length of time of a single intravascular diagnosis procedure. In one embodiment, the predetermined duration can correspond to the approximate length of time of multiple diagnosis procedures, such as three procedures. In one embodiment, the predetermined duration can be twelve hours or twenty-four hours or several days. In one aspect of the disclosed technology, the portable display unit 104 can include one or more batteries 116 that are configured to power the portable display unit 104 for the desired duration, such that the batteries 116 are substantially depleted at the end of the desired duration. In one embodiment, the one or more batteries 116 are non-rechargeable, so that the portable display unit 104 is disposed after the batteries 116 are depleted. In one embodiment, the power management unit 122 can control the operating time of the portable display unit 104 by preventing the portably display unit 104 from powering down after the display screen 114 is turned on. In such an embodiment, the portable display unit 104 will operate continuously until the batteries 116 are depleted or substantially depleted. The portable display unit 104 can be disposed prior to the batteries 116 being depleted, while the portable display unit 104 is still operable.


In one embodiment, the portable display unit 104 can track the number of diagnosis procedures performed and can be configured to be inoperable after a particular number of procedures has been performed. In one embodiment, the portable display unit 104 can track the number of diagnosis procedures performed by the number of times the portable display unit 114 has been turned on and/or off. In one embodiment, the portable display unit 104 can be configured to be inoperable after a single diagnosis procedure has been performed. In one aspect of the disclosed technology, the power management unit 122 can prevent the portable display unit 104 from being powered on after the particular number of procedures has been reached. The batteries 116 can be rechargeable and can be recharged by a power source of the portable display unit 104 and/or by a power source external to the portable display unit 104. Even when the batteries 116 are not yet depleted, the power management unit 122 can cause the portable display unit 104 to be inoperable by preventing the batteries 116 from powering the portable display unit 104.


The intravascular diagnosis procedure will now be described with continuing reference to FIG. 1 and with reference to FIGS. 7-11. Diagnosing the severity of one or more stenoses within the vasculature of a patient has been studied based on hemodynamic pressure measurements distal to a stenosis in comparison with aortic output pressure. The ratio of pressure distal to a stenosis to the aortic output pressure is known as “factional flow reserve”, or FFR. The value of the FFR indicates the severity of the stenosis, and clinical data provides guidance on the type of surgical procedure that would be effective for particular FFR ranges.


The disclosed technology includes multiple ways of computing FFR, including what will be referred to herein as “push-forward FFR”, “pull-back FFR”, and “simultaneous FFR”. Each of these can be implemented by software code or machine code stored in memory/storage 118 of the portable display unit 104 (FIG. 1). The processor 124 can execute the software code to compute the FFR, and the resulting information can be displayed on the display screen 114. Each of the computation methods will now be described.


Simultaneous Fraction Flow Reserve


Simultaneous FFR involves simultaneous pressure readings from two separate pressure sensors, and a computation of FFR in real-time as the pressure readings from the two separate pressure sensors are received. Referring to FIG. 1 and FIG. 9, one pressure sensor is located in the monitoring guidewire 102, and is used to measure pressure distal to a stenosis in a patient. The pressure readings can be communicated by the communication unit 112 of the monitoring guidewire 102 to the communication unit 120 of the portable display unit 104 (902). This communication can be a wireless communication or can be a wireline communication through, for example, the connector illustrated in FIG. 3. The other pressure sensor can measure aortic output pressure and is external to the apparatus 100 of FIG. 1. The portable display unit 104 can designate the received pressure measurements as pressure distal to a stenosis (904). The external sensor readings can be communicated to the communication unit 120 of the portable display unit by, for example, the communication port illustrated in FIG. 3 (906). The portable display unit 104 can designate the received pressure measurements as pressure proximal to a stenosis (908). The portable display unit 104 can compute the simultaneous FFR as the pressure measurements are received (910), by the formula: FFR=(Psensor−Pra)/(Pport−Pra), where:


Pport are moving means over time of real-time pressure measurements received at the communications port,


Psensor are moving means over time of real-time pressure measurements from the pressure sensor in the distal region of the core wire of the monitoring guidewire, and


Pra is a constant, which can be zero or another constant value.


In one embodiment, the moving means over time can compute the mean over a window of time that spans one heartbeat. In other embodiments, the window of time can span less than one heartbeat or more than one heartbeat. As new sensor measurements are received over time (902, 906), the window can include newer measurements and remove older measurements to compute the moving means.


The portable display unit 104 can receive pressure measurements and can compute the simultaneous FFR based on the received measurements. The portable display unit 104 can store the received pressure measurements and/or the computed simultaneous FFR in memory/storage 118, and can display the computed simultaneous FFR and/or a graph of the received pressure measurements on the display screen 114 (912).


Push-Forward Fractional Flow Reserve


In contrast to simultaneous FFR, the push-forward FFR does not receive external pressure measurements. With continuing reference to FIG. 1, push-forward FFR is computed using pressure measurements from only the pressure sensor(s) 108 in the distal region of the monitoring guidewire 102. Using traditional angiography, a stenosis can be located and, as shown in FIG. 8, the monitoring guidewire can be inserted into a patient to a point proximal to the stenosis. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104 (1002). The portable display unit 104 can store the measurements in this position in the memory/storage 118 as pressure proximal to a stenosis (1004). Next, the monitoring guidewire 102 can be pushed forward past the stenosis to a point distal to the stenosis, as illustrated in FIG. 7. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104 (1006). The portal display unit 104 can designate the pressure measurements received at this position as pressure distal to the stenosis (1008). The processor 124 can compute the push-forward FFR (1010) by the formula: FFR=(Psensor−Pra)/(Psaved−Pra), where:


Psaved are moving means over time of recorded pressure measurements proximal to the stenosis,


Psensor are moving means over time of real time pressure measurements distal to the stenosis, and


Pra is a constant, which can be zero or another constant value.


Aspects of computing the moving means over time were described above in connection with simultaneous FFR, and such aspects apply to push-forward FFR as well.


The portal display unit 104 can display the computed push-forward FFR and/or a graph of the received and stored pressure measurements (1012).


Push-forward FFR can be computed in the case of one stenosis and can also be computed in the case of multiple stenosis. In either case, Psaved are moving means over time of pressure measurements proximal to all of the stenosis. In one embodiment, Psaved are moving means over time computed based on recorded pressure measurements. In one embodiment, Psaved are moving means over time computed and recorded as pressure measurements are received, and the pressure measurements may or may not be recorded. For example, in the case of two stenoses, Psaved are based on pressure measurements proximal to both the first and second stenosis. When the monitoring guidewire pressure sensor 108 is pushed forward to a position between the first and the second stenosis, Psensor are based on real time pressure measurements between the two stenoses. Push-forward FFR can be calculated in this position and displayed on the display screen 114. When the monitoring guidewire pressure sensor 108 is pushed forward to a position distal to both the first and second stenoses, Psensor are based on real time pressure measurements distal to both of the two stenoses. Push-forward FFR can be calculated in this position and displayed on the display screen 114. Thus, push-forward FFR enables FFR to be computed and displayed as the monitoring guidewire 102 is pushed forward across one or more stenoses in a blood vessel lumen. The only measurements and/or moving means that need to be recorded for push-forward FFR computations are pressure measurements and/or moving means of pressure measurements proximal to all stenoses, and this is performed at the outset.


Pull-back Fractional Flow Reserve


Similar to push-forward FFR, the pull-back FFR does not receive external pressure measurements. Rather, pull-back FFR is computed using pressure measurements from only the pressure sensor(s) 108 in the distal region of the monitoring guidewire 102. Using traditional angiography, a stenosis can be located and, as shown in FIG. 7, the monitoring guidewire can be inserted into a patient to a point distal to the stenosis. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104 (1102). The portable display unit 104 can store the measurements in this position in the memory/storage 118 as pressure distal to a stenosis (1104). Next, the monitoring guidewire 102 can be pulled back through the stenosis to a point proximal to the stenosis, as illustrated in FIG. 8. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104 (1106). The portable display unit 104 can designate the measurements received in this position as pressure proximal to a stenosis (1108). The processor 124 can compute the pull-back FFR (1110) by the formula:

FFR=(Psaved−Pra)/(Psensor−Pra)

where:


Psaved are moving means over time of recorded pressure measurements distal to the stenosis,


Psensor are moving means over time of real time pressure measurements proximal to the stenosis, and


Pra is a constant, which can be zero or another constant value.


Aspects of computing the moving means over time were described above in connection with simultaneous FFR, and such aspects apply to pull-back FFR as well.


The portal display unit 104 can display the computed pull-back FFR and/or a graph of the received and stored pressure measurements (1112).


Pull-back FFR can be computed in the case of one stenosis and can also be computed in the case of multiple stenosis. In either case, Psensor are based on real-time pressure measurements proximal to all of the stenosis, which are the final pressure measurements that are taken. For example, in the case of two stenoses, the monitoring guidewire pressure sensor 108 is initially placed at a position distal to both the first and the second stenoses. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. In one embodiment, Psaved_d1 are moving means over time computed later based on recorded pressure measurements. In one embodiment, Psaved_d1 are moving means over time computed and recorded while the pressure measurements are received in this position, and the pressure measurements may or may not be recorded. The memory/storage 118 can record the pressure measurements in this position and/or computed moving means over time based on such pressure measurements. Pull-back FFR cannot yet be calculated because there is no real-time measurement yet proximal to all of the stenoses. Next, the monitoring guidewire 102 can be pulled back through the first stenosis to a point between the first and second stenosis. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. In one embodiment, Psaved_d2 are moving means over time computed later based on recorded pressure measurements. In one embodiment, Psaved_d1 are moving means over time computed and recorded while the pressure measurements are received in this position, and the pressure measurements may or may not be recorded. The memory/storage 118 can record the pressure measurements in this position and/or computed moving means over time based on such pressure measurements. Once again, pull-back FFR cannot yet be calculated because there is no real-time measurement yet proximal to all of the stenoses. Lastly, the monitoring guidewire 102 can be pulled back through the second stenosis to a point proximal to both the first and second stenosis. Real-time pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. Only at this point are there enough measurements to compute the two pull-back FFR: FFR1=(Psaved_d1−Pra)/(Psensor−Pra) and FFR2=(Psaved_d2−Pra)/(Psensor−Pra). Therefore, pull-back FFR does not allow FFR to be calculated and displayed as the monitoring guidewire is being pulled back through multiple stenoses.


Accordingly, three computations for fractional flow reserve have been described above in connection with FIGS. 7-11. In one aspect of the disclosed technology, and with reference to FIG. 1, the portable display unit 104 is configured with capability to compute fractional flow reserve using any of the three ways. In one embodiment, the portable display unit 104 can be configured to automatically use one of the three ways of computing fractional flow reserve. In one embodiment, the portable display unit 104 can be configured to automatically select one of the three ways of computing fractional flow reserve when a condition is present and to automatically select another of the three ways of computing fractional flow reserve when other conditions are present. In one embodiment, the portable display unit 104 can be configured to permit a user to manually select one of the three ways of computing fraction flow reserve.


The disclosed technology measures pressure and calculates fractional flow reserve (FFR). FFR is a calculation that has been clinically demonstrated to assist in determining whether to treat or not to treat an intermediate coronary lesion. Using the disclosed technology will thus assist a physician in determining what to do with an intermediate lesion. The disclosed FFR equations are exemplary and do not limit the scope of the disclosed technology. Other ways to compute FFR are contemplated to be within the scope of the disclosed technology.


The illustrations, embodiments, and specifications disclosed herein are exemplary and do not limit the spirit and scope of the disclosed technology. Combinations of one or more disclosed embodiments or specification, or portions of one or more embodiments or specifications, are contemplated as being within the scope of the disclosed technology.

Claims
  • 1. A portable apparatus for intravascular diagnosis, the portable apparatus comprising: a monitoring guidewire comprising a core wire and a sensor disposed in a distal region of the core wire;a display unit configured to be inoperable after a duration of use, the display unit comprising a processor, a main housing, and a display screen, wherein the display unit is capable of receiving communication from the monitoring guidewire, is configured to perform computations using the processor based on communications received from the monitoring guidewire, and is configured to display information on the display screen based on the computations, the display unit further comprising one or more non-rechargeable batteries configured to power the display unit; anda connector connected to the display unit and configured to be attachable to and detachable from the monitoring guidewire, the connector configured to establish a communicative connection with the monitoring guidewire when the monitoring guidewire is attached to the connector,wherein the display screen is folded in the main housing in a folded position before use,wherein pivoting the display screen from the folded position to an open position acts as an ON switch that enables the one or more non-rechargeable batteries to power the display unit, wherein the display unit being configured to be inoperable after the duration of use includes, after the display screen is turned on, the display unit operating continuously until the one or more non-rechargeable batteries are depleted, andwherein the display unit has no capability of being turned off after the display screen is turned on.
  • 2. The portable apparatus of claim 1, when the monitoring guidewire is not electrically or mechanically connected to the connector the display unit and the monitoring guidewire communicate wirelessly.
  • 3. The portable apparatus of claim 1, further comprising a torquer configured to engage the monitoring guidewire to control the monitoring guidewire within a vasculature of a patient.
  • 4. The portable apparatus of claim 1, wherein the monitoring guidewire further comprises a housing surrounding the sensor, the housing being laser etched to provide flexibility for the housing.
  • 5. The portable apparatus of claim 1, wherein the monitoring guidewire further comprises a flexible coil surrounding the sensor, the coil having a portion over the sensor that creates a window where the sensor is located.
  • 6. The portable apparatus of claim 1, wherein the sensor is a pressure sensor and communication from the monitoring guidewire includes measurements from the pressure sensor, and wherein the computations using the processor include computing fractional flow reserve based on pressure measurements from only the pressure sensor disposed in the distal region of the core wire.
  • 7. The portable apparatus of claim 6, wherein the fraction flow reserve is computed based on: recorded pressure measurements proximal to a first stenosis, anddistal pressure measurements distal to the first stenosis, the distal pressure measurements being measured after the recorded pressure measurements are recorded.
  • 8. The portable apparatus of claim 7, wherein the distal pressure measurements are measured distal to the first stenosis and proximal to a second stenosis.
  • 9. The portable apparatus of claim 7, wherein: the recorded pressure measurements are measured proximal to the first stenosis and proximal to a second stenosis, andthe distal pressure measurements are measured distal to the first stenosis and distal to the second stenosis.
  • 10. The portable apparatus of claim 6, wherein the fraction flow reserve is computed based on: recorded pressure measurements distal to a first stenosis, andproximal pressure measurements proximal to the first stenosis, the proximal pressure measurements being measured after the recorded pressure measurements are recorded.
  • 11. The portable apparatus of claim 10, wherein the proximal pressure measurements are measured proximal to the first stenosis and distal to a second stenosis.
  • 12. The portable apparatus of claim 10, wherein: the recorded pressure measurements are measured distal to the first stenosis and distal to a second stenosis, andthe proximal pressure measurements are measured proximal to the first stenosis and proximal to the second stenosis.
  • 13. The portable apparatus of claim 6, wherein the display unit displays on the display screen the fractional flow reserve.
  • 14. The portable apparatus of claim 6, wherein the display unit displays on the display screen a graph of the pressure measurements.
  • 15. The portable apparatus of claim 1, the display unit further comprising a communications port configured to receive communications that include pressure measurements.
  • 16. The portable apparatus of claim 15, wherein the computations using the processor include computing fractional flow reserve based on: first pressure measurements received at the communications port, andsecond pressure measurements from the sensor disposed in the distal region of the core wire.
  • 17. The portable apparatus of claim 15, wherein the display unit is configured with capability to compute fractional flow reserve in at least two ways comprising: computing fractional flow reserve based on pressure measurements from only the sensor disposed in the distal region of the core wire, and computing fractional flow reserve based on the pressure measurements from the sensor and based on pressure measurements received at the communications port.
  • 18. The portable apparatus of claim 17, the display unit being configured to automatically use one of the at least two ways of computing fractional flow reserve.
  • 19. The portable apparatus of claim 17, the display unit being configured to permit a user to manually select one of the at least two ways of computing fraction flow reserve.
  • 20. The portable apparatus of claim 1, wherein the monitoring guidewire is configured to be disposed after a single intravascular diagnosis procedure, and wherein the display unit being configured to be inoperable after the duration of use includes the display unit operating for multiple intravascular diagnosis procedures.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 61/985,858, filed Apr. 29, 2014, and U.S. Provisional Application No. 61/841,517, filed Jul. 1, 2013. The entire contents of each and every priority application are hereby incorporated by reference herein.

US Referenced Citations (227)
Number Name Date Kind
4691709 Cohen Sep 1987 A
4777951 Cribier et al. Oct 1988 A
4867173 Leoni Sep 1989 A
4884579 Engelson Dec 1989 A
4901731 Millar Feb 1990 A
4928693 Goodin et al. May 1990 A
4936310 Engstrom et al. Jun 1990 A
4941473 Tenerz et al. Jul 1990 A
4953553 Tremulis Sep 1990 A
5040543 Badera et al. Aug 1991 A
5063935 Gambale Nov 1991 A
5065769 de Toledo Nov 1991 A
5113868 Wise et al. May 1992 A
5163445 Christian et al. Nov 1992 A
5178153 Einzig Jan 1993 A
5226421 Frisbie et al. Jul 1993 A
5226423 Tenerz et al. Jul 1993 A
5313957 Little May 1994 A
5358409 Obara Oct 1994 A
5412994 Cook et al. May 1995 A
5413508 Obara May 1995 A
5509411 Littmann et al. Apr 1996 A
5517989 Frisbie et al. May 1996 A
5549109 Samson et al. Aug 1996 A
5668320 Cowan Sep 1997 A
RE35648 Tenerz et al. Nov 1997 E
5685322 Sung et al. Nov 1997 A
5690120 Jacobsen et al. Nov 1997 A
5699796 Littmann et al. Dec 1997 A
5715827 Corl et al. Feb 1998 A
5779631 Chance Jul 1998 A
5797856 Frisbie et al. Aug 1998 A
5807265 Itoigawa et al. Sep 1998 A
5873835 Hastings et al. Feb 1999 A
5916177 Schwager Jun 1999 A
5938624 Akerfeldt et al. Aug 1999 A
6004279 Crowley et al. Dec 1999 A
6017319 Jacobsen et al. Jan 2000 A
6089103 Smith Jul 2000 A
6106476 Corl et al. Aug 2000 A
6112598 Tenerz et al. Sep 2000 A
6142958 Hammarstroem et al. Nov 2000 A
6162182 Cole Dec 2000 A
6167763 Tenerz et al. Jan 2001 B1
6183424 Schwager Feb 2001 B1
6193669 Degany et al. Feb 2001 B1
6196980 Akerfeldt et al. Mar 2001 B1
6210339 Kiepen et al. Apr 2001 B1
6248083 Smith et al. Jun 2001 B1
6265792 Granchukoff Jul 2001 B1
6312380 Hoek et al. Nov 2001 B1
6336906 Hammarstrom et al. Jan 2002 B1
6343514 Smith Feb 2002 B1
6379308 Brockway et al. Apr 2002 B1
6409677 Tulkki Jun 2002 B1
6428336 Akerfeldt Aug 2002 B1
6440088 Jacobsen et al. Aug 2002 B1
6461301 Smith Oct 2002 B2
6471656 Shalman Oct 2002 B1
6565514 Svanerudh et al. May 2003 B2
6579246 Jacobsen et al. Jun 2003 B2
6615067 Hoek et al. Sep 2003 B2
6615667 Smith Sep 2003 B2
6672172 Tulkki et al. Jan 2004 B2
6767327 Corl et al. Jul 2004 B1
6779257 Kiepen et al. Aug 2004 B2
6908442 von Malmborg et al. Jun 2005 B2
6926674 Tenerz et al. Aug 2005 B2
6976965 Corl et al. Dec 2005 B2
7017420 Kalvesten et al. Mar 2006 B2
7018346 Griffin et al. Mar 2006 B2
7097620 Corl et al. Aug 2006 B2
7134994 Alpert et al. Nov 2006 B2
7263894 Tenerz Sep 2007 B2
RE39863 Smith Oct 2007 E
7326204 Paul et al. Feb 2008 B2
7450989 Svanerudh Nov 2008 B2
RE40608 Glover et al. Dec 2008 E
7628763 Noriega et al. Dec 2009 B2
7676910 Kiepen et al. Mar 2010 B2
7706891 Hastings et al. Apr 2010 B2
7711413 Feldman et al. May 2010 B2
7774051 Voth Aug 2010 B2
7775992 von Malmborg et al. Aug 2010 B2
7857810 Wang et al. Dec 2010 B2
7878981 Strother Feb 2011 B2
7878984 Jacobsen et al. Feb 2011 B2
7914466 Davis et al. Mar 2011 B2
7931603 Von Malmborg et al. Apr 2011 B2
7967761 Smith Jun 2011 B2
7967762 Corl et al. Jun 2011 B2
7988633 Hossack et al. Aug 2011 B2
7988639 Starks Aug 2011 B2
7998089 Smith Aug 2011 B2
8012145 Cawley Sep 2011 B2
8043312 Noriega et al. Oct 2011 B2
8052683 Podmore et al. Nov 2011 B2
8075490 Lofgren et al. Dec 2011 B2
8105246 Voeller et al. Jan 2012 B2
8162856 Williams et al. Apr 2012 B2
8162934 Potter Apr 2012 B2
8174395 Samuelsson et al. May 2012 B2
8182466 Stehr et al. May 2012 B2
8216151 Smith Jul 2012 B2
8229545 Afonso Jul 2012 B2
8231537 Ahmed et al. Jul 2012 B2
8277386 Ahmed et al. Oct 2012 B2
8317715 Belleville et al. Nov 2012 B2
8340766 Ryu et al. Dec 2012 B2
8343076 Sela et al. Jan 2013 B2
8376991 Kauphusman et al. Feb 2013 B2
8382689 Sliwa et al. Feb 2013 B2
8391956 Zellers et al. Mar 2013 B2
8403868 Von Malmborg et al. Mar 2013 B2
8414568 Harlan Apr 2013 B2
8419647 Corl et al. Apr 2013 B2
8437832 Govari et al. May 2013 B2
8468919 Christian et al. Jun 2013 B2
8480636 Khieu et al. Jul 2013 B2
8485985 Manstrom et al. Jul 2013 B2
8551020 Chen et al. Oct 2013 B2
8551021 Voeller et al. Oct 2013 B2
8556914 Vita Oct 2013 B2
8641633 Smith Feb 2014 B2
8657789 Guo et al. Feb 2014 B2
8684962 Kirschenman et al. Apr 2014 B2
8684999 Tegg et al. Apr 2014 B2
8696584 Kassab Apr 2014 B2
8702613 Kassab Apr 2014 B2
8734440 Wu May 2014 B2
8734699 Heideman et al. May 2014 B2
8755860 Paul et al. Jun 2014 B2
8758333 Harlan Jun 2014 B2
8764683 Meller et al. Jul 2014 B2
8777929 Schneider et al. Jul 2014 B2
8795254 Layman et al. Aug 2014 B2
8818485 Govari et al. Aug 2014 B2
8858591 Preinitz et al. Oct 2014 B2
8915865 Jacobsen et al. Dec 2014 B2
8936559 Strommer et al. Jan 2015 B2
8979837 de la Rama et al. Mar 2015 B2
8989849 Milner et al. Mar 2015 B2
8998826 Hauck et al. Apr 2015 B2
9301810 Amiri et al. Apr 2016 B2
9326756 Stangenes et al. May 2016 B2
20020072880 Svanerudh Jun 2002 A1
20030023190 Cox Jan 2003 A1
20030032886 Dgany et al. Feb 2003 A1
20030069522 Jacobsen et al. Apr 2003 A1
20030216621 Alpert Nov 2003 A1
20040225232 Malmborg et al. Nov 2004 A1
20050096566 Amott May 2005 A1
20060052700 Svanerudh Mar 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060135864 Westerlund Jun 2006 A1
20060211932 Al-Ali Sep 2006 A1
20070010762 Ressemann et al. Jan 2007 A1
20070078352 Pijls Apr 2007 A1
20070185485 Hauck et al. Aug 2007 A1
20070255144 Tulkki et al. Nov 2007 A1
20070255145 Smith et al. Nov 2007 A1
20070270741 Hassett et al. Nov 2007 A1
20070299403 Crowe et al. Dec 2007 A1
20070299424 Cumming et al. Dec 2007 A1
20070299436 Podmore et al. Dec 2007 A1
20070299438 Holzbaur et al. Dec 2007 A1
20080091193 Kauphusman et al. Apr 2008 A1
20080140101 Carley et al. Jun 2008 A1
20080200773 Pop Aug 2008 A1
20080221438 Chen et al. Sep 2008 A1
20080221601 Huynh et al. Sep 2008 A1
20080262474 Northrop Oct 2008 A1
20090036832 Skujins et al. Feb 2009 A1
20090171345 Miller et al. Jul 2009 A1
20090177119 Heidner et al. Jul 2009 A1
20100125197 Fishel May 2010 A1
20100137736 Addington et al. Jun 2010 A1
20100228112 Von Malmborg Sep 2010 A1
20100234698 Manstrom Sep 2010 A1
20100268038 Smith Oct 2010 A1
20100305458 Pfeiffer et al. Dec 2010 A1
20100318000 Von Malmborg et al. Dec 2010 A1
20110004198 Hoch Jan 2011 A1
20110009694 Schultz Jan 2011 A1
20110054487 Farnan Mar 2011 A1
20110152721 Sela et al. Jun 2011 A1
20110160680 Cage et al. Jun 2011 A1
20110160832 Cohen Jun 2011 A1
20110178413 Schmitt Jul 2011 A1
20120172731 Smith Jul 2012 A1
20120278008 Davies et al. Nov 2012 A1
20120289808 Hubinette Nov 2012 A1
20130046190 Davies Feb 2013 A1
20130046202 Tsunezumi et al. Feb 2013 A1
20130076157 Stein Mar 2013 A1
20130102927 Hilmersson Apr 2013 A1
20130116579 Svanerudh May 2013 A1
20130131523 Suchecki et al. May 2013 A1
20130131663 Govari et al. May 2013 A1
20130172782 Hilmersson Jul 2013 A1
20130190633 Dorando et al. Jul 2013 A1
20130218032 Belleville Aug 2013 A1
20130237864 Mazar et al. Sep 2013 A1
20130274618 Hou et al. Oct 2013 A1
20130296692 Vanney et al. Nov 2013 A1
20130296718 Ranganathan et al. Nov 2013 A1
20130296722 Warnking et al. Nov 2013 A1
20130317372 Eberle et al. Nov 2013 A1
20130324842 Mittal et al. Dec 2013 A1
20130338538 Park et al. Dec 2013 A1
20140005558 Gregorich Jan 2014 A1
20140039325 Belleville Feb 2014 A1
20140058275 Gregorich et al. Feb 2014 A1
20140058715 Sharma et al. Feb 2014 A1
20140066790 Burkett et al. Mar 2014 A1
20140066791 Burkett Mar 2014 A1
20140081244 Voeller et al. Mar 2014 A1
20140107624 Belleville Apr 2014 A1
20140180028 Burkett Jun 2014 A1
20140187979 Burkett Jul 2014 A1
20140187983 Anderson Jul 2014 A1
20140276109 Gregorich Sep 2014 A1
20140276117 Burkett Sep 2014 A1
20140276223 Gustafsson Sep 2014 A1
20140276226 Meller et al. Sep 2014 A1
20140336620 Layman et al. Nov 2014 A1
20150032027 Lupton Jan 2015 A1
Foreign Referenced Citations (38)
Number Date Country
102202562 Sep 2011 CN
0879615 Nov 1998 EP
1125548 Aug 2001 EP
1310215 May 2003 EP
0877574 Oct 2003 EP
0973438 Nov 2003 EP
1433429 Jun 2004 EP
1076511 Aug 2004 EP
1125548 Apr 2005 EP
0968547 Aug 2005 EP
1012912 Dec 2005 EP
0907335 Sep 2006 EP
1837638 Sep 2007 EP
1849409 Oct 2007 EP
1055392 Mar 2008 EP
1922988 May 2008 EP
2042091 Apr 2009 EP
1608418 Jul 2009 EP
523337 Apr 2004 SE
2001021057 Mar 2001 WO
2003022122 Mar 2003 WO
2009020836 Feb 2009 WO
2011110817 Sep 2011 WO
2012000798 Jan 2012 WO
2012041905 Apr 2012 WO
2012061935 May 2012 WO
2012091783 Jul 2012 WO
2012173697 Dec 2012 WO
2013028737 Feb 2013 WO
2013092969 Jun 2013 WO
2013164682 Nov 2013 WO
2013169451 Nov 2013 WO
2014005095 Jan 2014 WO
2014025255 Feb 2014 WO
2014043704 Mar 2014 WO
2014105578 Jul 2014 WO
2014140883 Sep 2014 WO
2014149688 Sep 2014 WO
Non-Patent Literature Citations (44)
Entry
US 8,180,431 B2, 05/2012, Altmann et al. (withdrawn)
Partial European Search Report issued in corresponding application No. 14820180 dated Jan. 10, 2017.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration issued in corresponding application No. PCT/US2016/037389 dated Sep. 27, 2016.
B. Nudell, et al., “Fame II Good for FFR and PCI”, Credit Suisse Securities Research & Analytics, Americas/United States, Equity Research, Medical Supplies & Devices, Aug. 28, 2012, pp. 1-9.
M. Weinstein, et al. “Cardiovascular Devices, FAME II: The Drumbeat of Data Supporting Broader FFR Use Continues”, J.P. Morgan North America Equity Research, Aug. 28, 2012 pp. 1-6.
“PressureWire(TM) Certus(TM) with Agile Tip”, St. Jude Medical, 2012, pp. 1-2.
S. Sen, et al., “Development and Validation of a New Adenosine-Independent Index of Stenosis Severity From Coronary Wave-Intensity Analysis”, Journal of the American College of Cardiology, vol. 59, No. 15, Apr. 10, 2012, pp. 1392-1402.
R. Petraco et al., “Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry”, EuroIntervention 2013; 9: 91-101.
De Bruyne et al, “Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease”, The New England Journal of Medicine, vol. 367, No. 11, Sep. 13, 2012, pp. 991-1001.
“St. Jude Medical executive: FAMI II trial's FFR products showing ‘significant growth’”, http://medcitynews.com/2012/01/fame-ii-trials-ffr-products-showing-significant-growth-st- . . . Jan. 19, 2012.
P. Tonino et al., “Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention”, The New England Journal of Medicine, vol. 360, No. 3, Jan. 15, 2009, pp. 213-224.
R. Petraco et al., “Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation”, EuroIntervention 2013; 8:1157-1165.
Written Opinion of the International Searching Authority issued in corresponding application No. PCT/US14/45171 dated Jan. 21, 2015.
PCT International Search Report issued in corresponding application No. PCT/US2014/045171 dated Jan. 21, 2015.
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013, PR Newswire—Thursday, May 23, 2013 (<http://m.yahoo.com/w/legobpengine/finance/news/volcano-announces-preliminary-results-advise-083000929.html?.intl=us&.lang=en-us>).
Instructions for use PrimeWire Presige(R) Plus, Pressure Guide Wire, Models: 9185/9185J-9300/9300J English, Volcano, Aug. 2012.
“Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines”, St. Jude Medical News Release, Dec. 16, 2009, pp. 1-3.
Instructions for Use for PressureWire(TM) Aeris (TM) Wireless FFR Measurement System, St. Jude Medical, Nov. 18, 2010. pp. 1-17.
Instructions for Use for PressureWire(TM) Receiver, St. Jude Medical, Oct. 18, 2010, pp. 1-15.
Quantien(TM) Integrated FFR Platform, St. Jude Medical, Jul. 10, 2013 (http://professional.sjm.com/products/vas/intravascular-diagnostics-imaging/ffr/quantien).
Quantien(TM) Integrated FFR Platform, Dicom Conformance Statement Model Quantien—Cardiology, Revision A, St. Jude Medical, 2012, pp. 1-29.
C. Berry et al., “VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in Every Practice)”, Journal of the American College of Cardiology, vol. 16, No. 13, 2013, pp. 1421-1427.
“ADVISE Study Results Demonstrate the Instant Wave-Free Ratio (TM), a Vasodilate Free Measure of Stenosis Severity, is Comparable to FFR”, Volcano Corporation and Imperial College London Support Study Presented During Late Breaking Clinical Trial Session at TCT Nov. 14, 2011.
Instructions for Use for “Combowire(R) Pressure/Flow Guide Wire Ref 9500 Series”, Volcano Corporation, Revision Date: Feb. 2012, pp. 1-4.
Instructions for Use for “FloWire(R) Doppler Guide Wire Ref 1400 Series—FloWire”, Volcano Corporation, Revision Date Feb. 2012.
Instructions for use for “PrimeWire PRESTIGE(R) Pressue Guide Wire”, Models: 8185/8185J-8300/8300J, Volcano Corporation, Revision Date Nov. 2012.
Instructions for use for “PrimeWire PRESTIGE(R) Plus Pressure Guide Wire”, Models: 9185/9185J-9300/9300J, Volcano Corporation, Revision Date Aug. 2012.
Instructions for use for “VERATTA(R) Pressue Guide Wire”, Models: 10185/10185J-10300/10300J, Volcano Corporation, Revision Date Jan. 2014.
InvestorPlace, “Volcano, St. Jude: 2 hearts beat as one. The Companies dominate a potential $2 billion test market.” Jan. 14, 2013 (http://money.msn.com/top-stocks/post.aspx?post=3bb89ca7-9959-4173-910e-eee3fc37a742).
J. Brosky, “Drug-free lesion assessment rivals fractional flow reserve”, Medical Device Daily, EuroPCR May 29, 2013 (http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorl . . . ).
Volcano Corporation S5/S5i (Chinese), www.dragonmedical.com, retrieved from internet Dec. 22, 2013.
“Wi-Box(TM) Cath Lab Installation and FAQ Dec. 2011”, St. Jude Medical, 2011.
“FFR and PressureWire(TM) Certus”, St. Jude Medical, p. 1-34, retrieved from Internet Feb. 9, 2014.
“SJM PressureWire Certus IFU (2)”, St. Jude Medical, pp. 4-13, www.sjm.com, retrieved from internet Jun. 29, 2013.
“SJM RadiAnalyzer IFU”, 20645 IFU RANXpress ENG R03 2010-12.indd, St. Jude Medical, pp. 3-48; 2010.
“PressureWire(TM) Agile Tip Technology”, St. Jude Medical, p. 1-15; 2012.
Extended European Search Report issued in corresponding application No. 14820180.9 dated Mar. 20, 2017.
Chinese First Office Action issued in corresponding application No. 201480002922.4 dated Dec. 12, 2017.
Australian Examination Report No. 1 for Australian Appln. No. AU 2014284381 dated Apr. 6, 2018 (3 pages).
De Bruyne et al., “Coronary Flow Reserve Calculated From Pressure Measurements in Humans. Validation With Jositron Emission Tomography,” Circulation, Journal of the American Heart Association, Mar. 1994, vol. 89, No. 3, pp. 1013-1022.
Allie et al., “Pressure-Sensing Guidewire Analysis in RAS,” Techniques, Endovascular Today, Oct. 2004, pp. 14-26.
Australian Examination Report No. 2 for Australian Appln. No. AU 2014284381 dated Dec. 7, 2018 (3 pages).
Examination Report issued by the Australian Patent Office dated Mar. 19, 2020 in corresponding Australian Patent Application No. 2016282495.
Communication issued by the European Patent Office dated May 20, 2020 in corresponding European Patent Application No. 14820180.9.
Related Publications (1)
Number Date Country
20150005648 A1 Jan 2015 US
Provisional Applications (2)
Number Date Country
61985858 Apr 2014 US
61841517 Jul 2013 US